Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model (original) (raw)
- Experimental Oncology
- Published: 01 May 1990
British Journal of Cancer volume 61, pages 659–662 (1990)Cite this article
- 164 Accesses
- 69 Citations
- 6 Altmetric
- Metrics details
Abstract
Studies with a conjugate of carboxypeptidase G2 (CPG2) and the F(ab')2 fragment of monoclonal anti-CEA antibody, A5B7, have shown specific localisation in a human colon tumour xenograft, LS174T, growing in nude mice. The conjugate reaches a peak concentration in the tumour within 24 h but enzyme activity in blood remains above a critical value for therapeutic purposes for several days. Here we describe a new monoclonal antibody, SB43, raised against CPG2 which is capable of reducing enzyme activity in blood. In vitro studies demonstrated specific binding of SB43 to CPG2 causing inactivation. Moreover, in the nude mouse model SB43 was also capable of inactivating the enzyme in the circulation within minutes of administration. Radiolabelled native SB43 persisted in blood for several days and appreciable non-specific uptake into the xenograft was also observed. Uptake of SB43 by the tumour, with possible inactivation of CPG2 at this site, could be limited by first coupling the antibody to galactose. This ensured recognition and excretion of SB43 and SB43-enzyme complexes via the liver and their rapid removal from the circulation. Galactosylation had no effect on the ability of SB43 to inactivate the enzyme.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Medical Oncology, Charing Cross Hospital, London, UK
SK Sharma
Authors
- SK Sharma
You can also search for this author inPubMed Google Scholar - KD Bagshawe
You can also search for this author inPubMed Google Scholar - PJ Burke
You can also search for this author inPubMed Google Scholar - RW Boden
You can also search for this author inPubMed Google Scholar - GT Rogers
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Sharma, S., Bagshawe, K., Burke, P. et al. Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.Br J Cancer 61, 659–662 (1990). https://doi.org/10.1038/bjc.1990.149
- Issue Date: 01 May 1990
- DOI: https://doi.org/10.1038/bjc.1990.149